Source: Breathe 2008; 5: 101-104



Rating:

Share or cite this content

Citations should be made in the following way:
Rare and 'orphan' lung diseases. Breathe 2008; 5: 101-104

Member's Comments

No comment yet.

Related content which might interest you: Rare and orphan lung diseases Source: ISSN=ISSN 1810-6838, ISBN=, page=146 Year: 2005 Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to? Source: Eur Respir Rev 2015; 24: 375-377 Year: 2015 Phenotype heterogeneity in a familial "brain lung thyroid syndrome" related to a novel NKX-2.1 mutation Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Orphan lung diseases Source: Annual Congress 2008 - Paediatric year in review Year: 2008 Rare pulmonary disease and orphan drugs: a path to the future Source: Eur Respir Rev, 28 (153) 190115; 10.1183/16000617.0115-2019 Year: 2019 Bronchiectasis: how to be an orphan with many parents? Source: Eur Respir J 2016; 47: 10-13 Year: 2016 Toward better management of rare and orphan pulmonary diseases Source: Eur Respir J 2016; 47:1334-1335 Year: 2016 Global effort against rare and orphan diseases Source: Annual Congress 2013 –European Respiratory Review: what's hot in pulmonary medicine Year: 2013 Global effort against rare and orphan diseases Source: Eur Respir Rev 2012 21:171-172 Year: 2012 Diagnostic approach to environmental/occupational pulmonary disease; how to differentiate from 'idiopathic' lung disease Source: Annual Congress 2004 - PG10 - Occupational and environmental disorders of the lung parenchyma Year: 2004 Rare pulmonary diseases: a common fight Source: Eur Respir Rev, 26 (145) 170059; 10.1183/16000617.0059-2017 Year: 2017 Orphan ILD: a spectrum of rare and/or neglected diseases Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases Year: 2008 Interstitial and orphan lung diseases: contribution of the pathologist Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician Year: 2010 Is toll like receptor 4 a common pathway hypothesis for development of lung cancer and idiopathic pulmonary fibrosis? Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Unclassified or unclassifiable interstitial lung disease: confusing or helpful disease category? Source: Eur Respir J 2013; 42: 576-579 Year: 2013 COPD; IPF; lung cancer in same individual: Can it be called 'AJMERITES SYNDROME? Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Treatment of lymphangioleiomyomatosis: building evidence in orphan diseases Source: Eur Respir J 2014; 43: 966-969 Year: 2014 Rare interstitial lung diseases Source: School Course 2014 - Interstitial lung diseases Year: 2014